Showing results (751-760 of 823) with videos related to
Sort By:
Pageof 83
Journal of Drug Targeting|May 1, 2010
Enhancing chemotherapeutic drug inhibition on tumor growth by ultrasound: an in vivo experimentYing-Zheng Zhao, Cui-Tao Lu, Zhi-Cai Zhou, et al.Cancers|April 30, 2021
Evolutionary Trajectories and Genomic Divergence in Localized Breast Cancers after Ipsilateral Breast Tumor RecurrenceChia-Hsin Wu, Hsien-Tang Yeh, Chia-Shan Hsieh, et al.Medicine|October 31, 2020
Plastic wrap combined with alcohol wiping is an effective method of preventing bacterial colonization on mobile phonesYen-Hung Wu, Chao-Ju Chen, Hsiu-Yueh Wu, et al.Journal of Cardiovascular Electrophysiology|July 27, 2010
Right-sided free wall accessory pathway refractory to conventional catheter ablation: lessons from 3-dimensional electroanatomic mappingMing Long Chen, Bing Yang, Wei Zhu Ju, et al.Journal of Ethnopharmacology|March 19, 2016
Protection of tauroursodeoxycholic acid on high glucose-induced human retinal microvascular endothelial cells dysfunction and streptozotocin-induced diabetic retinopathy ratsChun-Fei Wang, Jia-Rui Yuan, Dong Qin, et al.Anticancer Research|December 11, 2013
Quality of life assessment in Taiwanese patients with bone metastases from breast cancer receiving zoledronic acidTa-Chung Chao, Dar-Ren Chen, Tsu-Yi Chao, et al.American Journal of Cancer Research|February 10, 2022
De-glycosylated membrane PD-L1 in tumor tissues as a biomarker for responsiveness to atezolizumab (Tecentriq) in advanced breast cancer patientsFu Ou-Yang, Chung-Liang Li, Chia-Chi Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2011
In vivo positron emission tomography imaging of protease activity by generation of a hydrophobic product from a noninhibitory protease substrateChih-Hung Chuang, Kuo-Hsiang Chuang, Hsin-Ell Wang, et al.Cancer|March 21, 2019
Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (CBCSG-036): A randomized, controlled, multicenter trialKe-Da Yu, Si-Yu Wu, Guang-Yu Liu, et al.Cancer Research|September 14, 2011
FOXO3a-Dependent Mechanism of E1A-Induced ChemosensitizationJen-Liang Su, Xiaoyun Cheng, Hirohito Yamaguchi, et al.Pageof 83